ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Bio Medica Laboratories Limited has issued a notice for its 11th Annual General Meeting, scheduled for September 28, 2026, to conduct ordinary and special business.
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the company effective September 2, 2026.
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the Company, effective from September 02, 2026.
Bio Medica Laboratories announced the outcome of its board meeting, approving the 11th AGM notice, book closure dates, and the appointment of a Secretarial Auditor.
Bio Medica Laboratories shareholders approved multiple resolutions via postal ballot, including the disinvestment of subsidiary Vitamax Private Limited and related party transactions. The results are official.
Bio Medica Laboratories Limited has scheduled a board meeting for September 2, 2026, to discuss general business matters.
Bio Medica Laboratories appointed Ms. Khushi Gupta as Company Secretary and Compliance Officer effective August 14, 2026. She succeeds Ms. Pratiksha Bhandari, who resigned citing personal reasons.
Bio Medica Laboratories Limited reported non-applicability of the Corporate Governance Report for the quarter ending June 30, 2026. The company claims exemption as an SME entity.
Bio Medica Laboratories Ltd reported revenue from operations of ₹43.1 Cr and net profit of ₹11.9 Cr for H2 FY26.
Bio Medica Laboratories Limited announced the voting results of a postal ballot. Shareholders approved the alteration of the company's Memorandum of Association main objects.